AI company Anthropic’s chatbot Claude has discovered a novel enzyme system with properties resembling CRISPR, a gene-editing technology. The finding comes from Anthropic’s new life sciences research ...

Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways to create genuinely new gene-editing enzymes with properties that have not ...

Anthropic says 950 Claude agents scanned more than 200,000 reverse transcriptases in 21 hours, identifying a novel system called ART that researchers later validated in a laboratory ...

Gene editing is a highly precise and powerful technology that allows scientists to insert, delete, modify or replace DNA bases in living organisms. It has a variety of uses, including correcting ...

BCC Research examines how AI is improving gene transfer technologies through data-driven design, delivery optimization and ...

Anthropic PBC’s announcement that its Claude AI model discovered an enzyme system that resembled an earlier breakthrough gene editing technology was met with caution by some experts in the field, who ...

Pharmaceutical & Biotech Stock Introductory Series Part 14/17]IntroductionPrime Medicine (PRME) is a "drug discovery" company ...

AI giant announces discovery amid global debate about how to safeguard against catastrophic risks.

Anthropic says its Claude AI models have discovered a new biological system resembling CRISPR inside bacteria-infecting viruses. The finding, still unverified, could point to a new tool for gene ...

Editas Medicine stock trades steadily while investors digest recent gene editing developments and look ahead to the company’s next earnings update. EDIT, US28106W1036, Illustration mit AI erstellt.